Article Figures & Data
Figures
- FIGURE 1.
Graphic representation of LP (A), EP (B), and EF (C) for CCK-1 and CCK-2 doses. Only the data corresponding to those for patients with an abnormal EF (≤40%) in the first study are shown. Horizontal bars represent mean values.
Tables
- TABLE 1
Characteristics of 4 Groups for Analyzing Effects of CCK Doses on Gallbladder Dynamics, LP, EP, and EF
Group Women/men (n) Mean age (range) (y) CCK dose Infusion time (min) Mean (SD) IDU/kg/min IDU/kg ng/kg LP (min) EP (min) EF (%) I 4/6 31 (18–50) 0.25 1.92 3 4 (2) 12 (3) 42.9 (19.4) 0.08 II 5/5 42 (30–66) 0.30 2.3 15 4 (2) 27 (4)† 58.4 (26.0) 0.02 III 6/4 34 (29–47) 0.40 3.07 20 4 (2) 30 (5)† 68.3 (18.1)† 0.02 IV 6/4 42 (28–65) 0.60 4.6 30 4 (2) 39 (4)‡ 77.5 (25.0)† 0.02 Total 21/19 37 (18–66) Parameter Mean (SD) Range LP (min) 4 (2) 2–12 EP (min) 28 (6) 14–35 EF (%) 74.2 (17.1) 38–96 - TABLE 3
LP, EP, and EF in 2 Studies of Phase 3 (CCK-1 and CCK-2 doses) for 44 Patients Each
Dose Mean (SD) LP (min) EP (min) EF (%) CCK-1 5.2 (3.7) 27.8 (8.9) 25.2 (8.2) CCK-2 5.0 (3.5) 28.9 (8.1) 31.1 (17.7)
